Skip to main content
SpringerLink
Log in

Characterization of acute renal allograft rejection by human serum proteomic analysis

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

To identify acute renal allograft rejection biomarkers in human serum, two-dimensional differential in-gel electrophoresis (2-D DIGE) and reversed phase high-performance liquid chromatography (RP-HPLC) followed by electrospray ionization mass spectrometry (ESI-MS) were used. Serum samples from renal allograft patients and normal volunteers were divided into three groups: acute rejection (AR), stable renal function (SRF) and normal volunteer (N). Serum samples were firstly processed using Multiple Affinity Removal Column to selectively remove the highest abundance proteins. Differentially expressed proteins were analyzed using 2-D DIGE. These differential protein spots were excised, digested by trypsin, and identified by RP-HPLC-ESI/MS. Twenty-two differentially expressed proteins were identified in serum from AR group. These proteins included complement C9 precursor, apolipoprotein A-IV precursor, vitamin D-binding protein precursor, beta-2-glycoprotein 1 precursor, etc. Vitamin D-binding protein, one of these proteins, was confirmed by ELISA in the independent set of serum samples. In conclusion, the differentially expressed proteins as serum biomarker candidates may provide the basis of acute rejection noninvasive diagnosis. Confirmed vitamin D-binding protein may be one of serum biomarkers of acute rejection. Furthermore, it may provide great insights into understanding the mechanisms and potential treatment strategy of acute rejection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hariharan S, Johnson CP, Bresnahan BA et al. Improved graft survival after renal transplantation in the United States, 1998–1996. N Engl J Med, 2000, 342(9):605–612

    Article  PubMed  CAS  Google Scholar 

  2. McLaren AJ, Fuggle SV, Welsh KI et al. Chronic allograft failure in human renal transplantation: a multivariate risk factor analysis. Ann Surg, 2000,232(1):98–103

    Article  PubMed  CAS  Google Scholar 

  3. Benfield MR, Herrin J, Feld L et al. Safety of kidney biopsy in pediatric transplantation: a report of the controlled clinical trials in pediatric transplantation trial of induction therapy study group. Transplantation, 1999,67(4):544–547

    Article  PubMed  CAS  Google Scholar 

  4. Traum AZ, Schachter AD. Transplantation proteomics. Pediatr Transplant, 2005,9(6):700–711

    Article  PubMed  CAS  Google Scholar 

  5. Solez K, Colvin RB, Racusen LC, et al. Banff’ 05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (’CAN’). Am J Transplant, 2007,7(3):518–526

    Article  PubMed  CAS  Google Scholar 

  6. Peng J, Elias JE, Thoreen CC, et al. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J Proteome Res, 2003,2(1): 43–50

    Article  PubMed  CAS  Google Scholar 

  7. Anderson NL, Polanski M, Pieper R, et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics, 2004, 3(4):311–326

    Article  PubMed  CAS  Google Scholar 

  8. Huang HL, Stasyk T, Morandell S, et al. Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/ MALDI-TOF/TOF and data validation by routine clinical assays. Electrophoresis, 2006,27(8):1641–1650

    Article  PubMed  CAS  Google Scholar 

  9. Schaub S, Wilkins JA, Nickerson P. Proteomics and renal transplantation: searching for novel biomarkers and therapeutic targets. Contrib Nephrol, 2008,160:65–75

    Article  PubMed  CAS  Google Scholar 

  10. Clarke W. Proteomic research in renal transplantation. Ther Drug Monit, 2006, 28(1):19–22

    Article  PubMed  CAS  Google Scholar 

  11. Schaub S, Wilkins JA, Antonovici M, et al. Proteomic-based identification of cleaved urinarybeta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am J Transplant, 2005,5(4 Pt 1):729–738

    Article  PubMed  CAS  Google Scholar 

  12. Wittke S, Haubitz M, Walden M, et al. Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am J Transplant, 2005, 5(10):2479–2488

    Article  PubMed  CAS  Google Scholar 

  13. El Essawy B, Otu HH, Choy B, et al. Proteomic analysis of the allograft response. Transplantation, 2006,82(2): 267–274

    Article  PubMed  CAS  Google Scholar 

  14. Voshol H, Brendlen N, Müller D, et al. Evaluation of biomarker discovery approaches to detect protein biomarkers of acute renal allograft rejection. J Proteome Res, 2005,4(4):1192–1199

    Article  PubMed  CAS  Google Scholar 

  15. Yu KH, Rustgi AK, Blair IA. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. J Proteome Res, 2005,4(5):1742–1751

    Article  PubMed  CAS  Google Scholar 

  16. Schiødt FV, Rossaro L, Stravitz RT, et al. Gc-globulin and prognosis in acute liver failure. Liver Transpl, 2005,11(10):1223–1227

    Article  PubMed  Google Scholar 

  17. Speeckaert MM, Glorieux GL, Vanholder R, et al. Vitamin D binding protein and the need for vitamin D in hemodialysis patients. J Ren Nutr, 2008,18(5):400–407

    Article  PubMed  Google Scholar 

  18. Zella LA, Shevde NK, Hollis BW, et al. Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology, 2008,149(7):3656–3667

    Article  PubMed  CAS  Google Scholar 

  19. Christakos S, Dhawan P, Liu Y, et al. New insights into the mechanisms of vitamin D action. J Cell Biochem, 2003,88(4):695–705

    Article  PubMed  CAS  Google Scholar 

  20. Mathieu C, Jafari M. Immunomodulation by 1,25-dihydroxyvitamin D3: therapeutic implications in hemodialysis and renal transplantation. Clin Nephrol, 2006,66(4):275–283

    PubMed  CAS  Google Scholar 

  21. Koga Y, Naraparaju VR, Yamamoto N. Antitumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice. Proc Soc Exp Biol Med, 1999,220(1):20–26

    Article  PubMed  CAS  Google Scholar 

  22. Yamamoto N, Suyama H, Ushijima N. Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). Int J Cancer, 2008, 122(2):461–467

    Article  PubMed  CAS  Google Scholar 

  23. Yamamoto N, Suyama H. Immunotherapy for prostate cancer with gc protein-derived macrophage-activating factor, GcMAF. Transl Oncol, 2008,1(2):65–72

    PubMed  Google Scholar 

  24. Nickeleit V, Andreoni K. Inflammatory cells in renal allografts. Front Biosci, 2008,13:6202–6213

    Article  PubMed  CAS  Google Scholar 

  25. Qi F, Adair A, Ferenbach D, et al. Depletion of cells of monocyte lineage prevents loss of renal microvasculature in murine kidney transplantation. Transplantation, 2008,86(9):1267–1274

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ Transplantation, Ministry of Education, Ministry of Health, Wuhan, 430030, China

    Ying Gao  (高 英), Ke Wu  (吴 轲), Yi Xu  (徐 逸), Hongmin Zhou  (周鸿敏), Wentao He  (何文涛), Weina Zhang  (张维娜), Lanjun Cai  (蔡兰军), Xingguang Lin  (林星光), Zemin Fang  (方泽民), Zhenlong Luo  (雒真龙), Hui Guo  (郭 晖) & Zhonghua Chen  (陈忠华)

Authors
  1. Ying Gao  (高 英)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ke Wu  (吴 轲)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yi Xu  (徐 逸)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hongmin Zhou  (周鸿敏)
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wentao He  (何文涛)
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Weina Zhang  (张维娜)
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lanjun Cai  (蔡兰军)
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xingguang Lin  (林星光)
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Zemin Fang  (方泽民)
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Zhenlong Luo  (雒真龙)
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hui Guo  (郭 晖)
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Zhonghua Chen  (陈忠华)
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This project was supported by a grant from National Basic Research 973 Program of China (No. 2009CB522407).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gao, Y., Wu, K., Xu, Y. et al. Characterization of acute renal allograft rejection by human serum proteomic analysis. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 29, 585–591 (2009). https://doi.org/10.1007/s11596-009-0511-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-009-0511-8

Key words

Search

Navigation